

HY-173296 · 50 mg
MedChemExpress · Cat: HY-173296
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/magl-in-222.htmlDescription
MAGL-IN-222 Compound ZQ-7 is a covalent inhibitor targeting monoacylglycerol lipase MAGL with an IC50 of 42.31 ?M. MAGL-IN-222 can reduce the breakdown of 2-arachidonoylglycerol 2-AG and increase the intracellular 2-AG level, thereby inhibiting the proliferation and migration of MDA-MB-231 breast cancer cells. MAGL-IN-222 can be used in the research of breast cancer and other related diseases.







